Group B Streptococcus and perinatal mortality

[en] The World Health Organization estimates that every year, one million neonatal deaths occur because of neonatal infection. Furthermore, an equal number of stillbirths are thought to be caused by infections. Here we discuss the role of Streptococcus agalactiae (group B Streptococcus, GBS) in neonatal disease and stillbirth.

Research center :

CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège

Disciplines :

Pediatrics
Laboratory medicine & medical technology
Immunology & infectious disease
Microbiology
Reproductive medicine (gynecology, andrology, obstetrics)

Author, co-author :

COOLS, Piet; Ghent University > Microbiology > Laboratory Bacteriology Research

MELIN, Pierrette ; Centre Hospitalier Universitaire de Liège - CHU > Service de microbiologie clinique

Language :

English

Title :

Group B Streptococcus and perinatal mortality

Publication date :

20 April 2017

Journal title :

Research in Microbiology

ISSN :

0923-2508

eISSN :

1769-7123

Publisher :

Elsevier, Paris, France

Volume :

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

http://dx.doi.org/10.1016/j.resmic.2017.04.002

Available on ORBi :

since 27 June 2017

Statistics

Number of views

109 (11 by ULiège)

Number of downloads

1 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

El Aila, N.A., Tency, I., Saerens, B., De Backer, E., Cools, P., dos Santos Santiago, G.L., et al. Strong correspondence in bacterial loads between the vagina and rectum of pregnant women. Res Microbiol 162 (2011), 506–513.
Schuchat, A., Group B Streptococcus. Lancet 353 (1999), 51–56.
Goldenberg, R.L., McClure, E.M., Saleem, S., Reddy, U.M., Infection-related stillbirths. Lancet 375 (2010), 1482–1490.
Lawn, J.E., Cousens, S., Zupan, J., Lancet neonatal survival steering T. 4 million neonatal deaths: when? Where? Why?. Lancet 365 (2005), 891–900.
Seale, A.C., Koech, A.C., Sheppard, A.E., Barsosio, H.C., Langat, J., Anyango, E., et al. Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya. Nat Microbiol, 1, 2016, 16067.
Simonsen, K.A., Anderson-Berry, A.L., Delair, S.F., Davies, H.D., Early-onset neonatal sepsis. Clin Microbiol Rev 27 (2014), 21–47.
Mukhopadhyay, S., Puopolo, K.M., Risk assessment in neonatal early onset sepsis. Semin Perinatol 36 (2012), 408–415.
Nizet, V., Klein, J.O., Bacterial sepsis and meningitis. S E, (eds.) Remington and Klein's infectious diseases of the fetus and newborn infant, 2011, 217–271.
Stoll, B.J., Hansen, N.I., Sanchez, P.J., Faix, R.G., Poindexter, B.B., Van Meurs, K.P., et al. Early onset neonatal sepsis: the burden of group B streptococcal and E. coli disease continues. Pediatrics 127 (2011), 817–826.
Cools, P., The role of Escherichia coli in reproductive health: state of the art. Res Microbiol 168 (2017), 892–901.
Puopolo, K.M., Bacterial and fungal infections. Cloherty, J.P.E., Eichenwald, E.C., Stark, A.R., (eds.) Manual of neonatal care, 2008.
Boyer, K.M., Gotoff, S.P., Strategies for chemoprophylaxis of GBS early-onset infections. Antibiot Chemother 1985:35 (1971), 267–280.
Ancona, R.J., Ferrieri, P., Williams, P.P., Maternal factors that enhance the acquisition of group-B streptococci by newborn infants. J Med Microbiol 13 (1980), 273–280.
Pass, M.A., Gray, B.M., Khare, S., Dillon, H.C. Jr., Prospective studies of group B streptococcal infections in infants. J Pediatr 95 (1979), 437–443.
Jelinkova, J., Grabovskaya, K.B., Ryc, M., Bulgakova, T.N., Totolian, A.A., Adherence of vaginal and pharyngeal strains of group B streptococci to human vaginal and pharyngeal epithelial cells. Zentralbl Bakteriol Mikrobiol Hyg A 262 (1986), 492–499.
Sobel, J.D., Myers, P., Levison, M.E., Kaye, D., Comparison of bacterial and fungal adherence to vaginal exfoliated epithelial cells and human vaginal epithelial tissue culture cells. Infect Immun 35 (1982), 697–701.
Tamura, G.S., Kuypers, J.M., Smith, S., Raff, H., Rubens, C.E., Adherence of group B streptococci to cultured epithelial cells: roles of environmental factors and bacterial surface components. Infect Immun 62 (1994), 2450–2458.
Zawaneh, S.M., Ayoub, E.M., Baer, H., Cruz, A.C., Spellacy, W.N., Factors influencing adherence of group B streptococci to human vaginal epithelial cells. Infect Immun 26 (1979), 441–447.
Konto-Ghiorghi, Y., Mairey, E., Mallet, A., Dumenil, G., Caliot, E., Trieu-Cuot, P., et al. Dual role for pilus in adherence to epithelial cells and biofilm formation in Streptococcus agalactiae. PLoS Pathog, 5, 2009, e1000422.
Maisey, H.C., Doran, K.S., Nizet, V., Recent advances in understanding the molecular basis of group B Streptococcus virulence. Expert Rev Mol Med, 10, 2008, e27.
Rajagopal, L., Understanding the regulation of Group B streptococcal virulence factors. Future Microbiol 4 (2009), 201–221.
Schubert, A., Zakikhany, K., Schreiner, M., Frank, R., Spellerberg, B., Eikmanns, B.J., et al. A fibrinogen receptor from group B Streptococcus interacts with fibrinogen by repetitive units with novel ligand binding sites. Mol Microbiol 46 (2002), 557–569.
Kwatra, G., Cunnington, M.C., Merrall, E., Adrian, P.V., Ip, M., Klugman, K.P., et al. Prevalence of maternal colonisation with group B Streptococcus: a systematic review and meta-analysis. Lancet Infect Dis 16 (2016), 1076–1084.
Verani, J.R., McGee, L., Schrag, S.J., Division of bacterial diseases NCfI, respiratory diseases CfDC, prevention. Prevention of perinatal group B streptococcal disease–revised guidelines from CDC, 2010. MMWR Recomm Rep 59 (2010), 1–36.
Stewardson-Krieger, P.B., Gotoff, S.P., Risk factors in early-onset neonatal group b streptococcal infections. Infection 6 (1978), 50–53.
Goldenberg, R.L., Hauth, J.C., Andrews, W.W., Intrauterine infection and preterm delivery. N Engl J Med 342 (2000), 1500–1507.
Galask, R.P., Varner, M.W., Petzold, C.R., Wilbur, S.L., Bacterial attachment to the chorioamniotic membranes. Am J Obstet Gynecol 148 (1984), 915–928.
Winram, S.B., Jonas, M., Chi, E., Rubens, C.E., Characterization of group B streptococcal invasion of human chorion and amnion epithelial cells in vitro. Infect Immun 66 (1998), 4932–4941.
Gase, K., Ozegowski, J., Malke, H., The Streptococcus agalactiae hylB gene encoding hyaluronate lyase: completion of the sequence and expression analysis. Biochim Biophys Acta 1398 (1998), 86–98.
Lin, B., Hollingshead, S.K., Coligan, J.E., Egan, M.L., Baker, J.R., Pritchard, D.G., Cloning and expression of the gene for group B streptococcal hyaluronate lyase. J Biol Chem 269 (1994), 30113–30116.
Espinoza, J., Chaiworapongsa, T., Romero, R., Edwin, S., Rathnasabapathy, C., Gomez, R., et al. Antimicrobial peptides in amniotic fluid: defensins, calprotectin and bacterial/permeability-increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes. J Matern Fetal Neonatal Med 13 (2003), 2–21.
Hemming, V.G., Nagarajan, K., Hess, L.W., Fischer, G.W., Wilson, S.R., Thomas, L.S., Rapid in vitro replication of group B Streptococcus in term human amniotic fluid. Gynecol Obstet Investig 19 (1985), 124–129.
Abbasi, I.A., Hemming, V.G., Eglinton, G.S., Johnson, T.R., Proliferation of group B streptococci in human amniotic fluid in vitro. Am J Obstet Gynecol 156 (1987), 95–99.
Ablow, R.C., Driscoll, S.G., Effmann, E.L., Gross, I., Jolles, C.J., Uauy, R., et al. A comparison of early-onset group B steptococcal neonatal infection and the respiratory-distress syndrome of the newborn. N Engl J Med 294 (1976), 65–70.
Baker, C.J., Early onset group B streptococcal disease. J Pediatr 93 (1978), 124–125.
Bergqvist, G., Holmberg, G., Rydner, T., Vaclavinkova, V., Intrauterine death due to infection with group B streptococci. Acta Obstet Gynecol Scand 57 (1978), 127–128.
Vollman, J.H., Smith, W.L., Ballard, E.T., Light, I.J., Early onset group B streptococcal disease: clinical, roentgenographic, and pathologic features. J Pediatr 89 (1976), 199–203.
Rubens, C.E., Raff, H.V., Jackson, J.C., Chi, E.Y., Bielitzki, J.T., Hillier, S.L., Pathophysiology and histopathology of group B streptococcal sepsis in Macaca nemestrina primates induced after intraamniotic inoculation: evidence for bacterial cellular invasion. J Infect Dis 164 (1991), 320–330.
Gibson, R.L., Lee, M.K., Soderland, C., Chi, E.Y., Rubens, C.E., Group B streptococci invade endothelial cells: type III capsular polysaccharide attenuates invasion. Infect Immun 61 (1993), 478–485.
Rubens, C.E., Smith, S., Hulse, M., Chi, E.Y., van Belle, G., Respiratory epithelial cell invasion by group B streptococci. Infect Immun 60 (1992), 5157–5163.
Nizet, V., Gibson, R.L., Chi, E.Y., Framson, P.E., Hulse, M., Rubens, C.E., Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infect Immun 64 (1996), 3818–3826.
Valentin-Weigand, P., Jungnitz, H., Zock, A., Rohde, M., Chhatwal, G.S., Characterization of group B streptococcal invasion in HEp-2 epithelial cells. FEMS Microbiol Lett 147 (1997), 69–74.
Pezzicoli, A., Santi, I., Lauer, P., Rosini, R., Rinaudo, D., Grandi, G., et al. Pilus backbone contributes to group B Streptococcus paracellular translocation through epithelial cells. J Infect Dis 198 (2008), 890–898.
Kreikemeyer, B., Gamez, G., Margarit, I., Giard, J.C., Hammerschmidt, S., Hartke, A., et al. Genomic organization, structure, regulation and pathogenic role of pilus constituents in major pathogenic Streptococci and Enterococci. Int J Med Microbiol 301 (2011), 240–251.
Telford, J.L., Barocchi, M.A., Margarit, I., Rappuoli, R., Grandi, G., Pili in gram-positive pathogens. Nat Rev Microbiol 4 (2006), 509–519.
Katzenstein, A.L., Davis, C., Braude, A., Pulmonary changes in neonatal sepsis to group B beta-hemolytic Streptococcus: relation of hyaline membrane disease. J Infect Dis 133 (1976), 430–435.
Edwards MSN, V., Baker, C.J., Group B streptococcal infections. Remington and Klein's infectious diseases of the fetus and newborn infant. 2011.
Jurgens, D., Sterzik, B., Fehrenbach, F.J., Unspecific binding of group B streptococcal cocytolysin (CAMP factor) to immunoglobulins and its possible role in pathogenicity. J Exp Med 165 (1987), 720–732.
Skalka, B., Smola, J., Lethal effect of CAMP-factor and UBERIS-factor–a new finding about diffusible exosubstances of Streptococcus agalactiae and Streptococcus uberis. Zentralbl Bakteriol A 249 (1981), 190–194.
Nizet, V., Kim, K.S., Stins, M., Jonas, M., Chi, E.Y., Nguyen, D., et al. Invasion of brain microvascular endothelial cells by group B streptococci. Infect Immun 65 (1997), 5074–5081.
Poyart, C., Reglier-Poupet, H., Tazi, A., Billoet, A., Dmytruk, N., Bidet, P., et al. Invasive group B streptococcal infections in infants, France. Emerg Infect Dis 14 (2008), 1647–1649.
Tazi, A., Disson, O., Bellais, S., Bouaboud, A., Dmytruk, N., Dramsi, S., et al. The surface protein HvgA mediates group B Streptococcus hypervirulence and meningeal tropism in neonates. J Exp Med 207 (2010), 2313–2322.
Ling, E.W., Noya, F.J., Ricard, G., Beharry, K., Mills, E.L., Aranda, J.V., Biochemical mediators of meningeal inflammatory response to group B Streptococcus in the newborn piglet model. Pediatr Res 38 (1995), 981–987.
Spellerberg, B., Pathogenesis of neonatal Streptococcus agalactiae infections. Microbes Infect 2 (2000), 1733–1742.
Baker, C.J., Kasper, D.L., Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 294 (1976), 753–756.
Baker, C.J., Edwards, M.S., Webb, B.J., Kasper, D.L., Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B Streptococcus. J Clin Investig 69 (1982), 394–404.
Levy, O., Jean-Jacques, R.M., Cywes, C., Sisson, R.B., Zarember, K.A., Godowski, P.J., et al. Critical role of the complement system in group B Streptococcus-induced tumor necrosis factor alpha release. Infect Immun 71 (2003), 6344–6353.
Melin, P., Efstratiou, A., Group B streptococcal epidemiology and vaccine needs in developed countries. Vaccine 31:Suppl. 4 (2013), D31–D42.
Schrag, S.J., Zywicki, S., Farley, M.M., Reingold, A.L., Harrison, L.H., Lefkowitz, L.B., et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 342 (2000), 15–20.
Verani, J.R., Schrag, S.J., Group B streptococcal disease in infants: progress in prevention and continued challenges. Clin Perinatol 37 (2010), 375–392.
Melin, P., Neonatal group B streptococcal disease: from pathogenesis to preventive strategies. Clin Microbiol Infect 17 (2011), 1294–1303.
Schrag, S.J., Zell, E.R., Lynfield, R., Roome, A., Arnold, K.E., Craig, A.S., et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 347 (2002), 233–239.
Dillon, H.C. Jr., Gray, E., Pass, M.A., Gray, B.M., Anorectal and vaginal carriage of group B streptococci during pregnancy. J Infect Dis 145 (1982), 794–799.
El Aila, N.A., Tency, I., Claeys, G., Saerens, B., Cools, P., Verstraelen, H., et al. Comparison of different sampling techniques and of different culture methods for detection of group B Streptococcus carriage in pregnant women. BMC Infect Dis, 10, 2010, 285.
Rosa-Fraile, M., Camacho-Munoz, E., Rodriguez-Granger, J., Liebana-Martos, C., Specimen storage in transport medium and detection of group B streptococci by culture. J Clin Microbiol 43 (2005), 928–930.
Baker, C.J., Goroff, D.K., Alpert, S., Crockett, V.A., Zinner, S.H., Evrard, J.R., et al. Vaginal colonization with group B Streptococcus: a study in college women. J Infect Dis 135 (1977), 392–397.
El Aila, N.A., Tency, I., Claeys, G., Verstraelen, H., Deschaght, P., Decat, E., et al. Comparison of culture with two different qPCR assays for detection of rectovaginal carriage of Streptococcus agalactiae (group B streptococci) in pregnant women. Res Microbiol 162 (2011), 499–505.
Platt, M.W., McLaughlin, J.C., Gilson, G.J., Wellhoner, M.F., Nims, L.J., Increased recovery of group B Streptococcus by the inclusion of rectal culturing and enrichment. Diagn Microbiol Infect Dis 21 (1995), 65–68.
CDC. 2010. https://www.cdc.gov/abcs/reports-findings/survreports/gbs10-suscept.html.
Fenton, L.J., Harper, M.H., Evaluation of colistin and nalidixic acid in Todd-Hewitt broth for selective isolation of group B streptocci. J Clin Microbiol 9 (1979), 167–169.
Rosa-Fraile, M., Dramsi, S., Spellerberg, B., Group B streptococcal haemolysin and pigment, a tale of twins. FEMS Microbiol Rev 38 (2014), 932–946.
Melin, P.H.P., Meex, C., De Mol, P., Evaluation of the StrepB select agar for the detection of group B streptococci from vaginal and rectovaginal specimens. European congress of clinical microbiology and infectious diseases, Barcelona, Spain, 2008.
Bergeron, M.G., Ke, D., Menard, C., Picard, F.J., Gagnon, M., Bernier, M., et al. Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med 343 (2000), 175–179.
Davies, H.D., Miller, M.A., Faro, S., Gregson, D., Kehl, S.C., Jordan, J.A., Multicenter study of a rapid molecular-based assay for the diagnosis of group B Streptococcus colonization in pregnant women. Clin Infect Dis 39 (2004), 1129–1135.
Puopolo, K.M., Madoff, L.C., Eichenwald, E.C., Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 115 (2005), 1240–1246.
Van Dyke, M.K., Phares, C.R., Lynfield, R., Thomas, A.R., Arnold, K.E., Craig, A.S., et al. Evaluation of universal antenatal screening for group B Streptococcus. N Engl J Med 360 (2009), 2626–2636.
CDC, Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for disease control and prevention. MMWR Recomm Rep 45 (1996), 1–24.
Aloisio, I., Mazzola, G., Corvaglia, L.T., Tonti, G., Faldella, G., Biavati, B., et al. Influence of intrapartum antibiotic prophylaxis against group B Streptococcus on the early newborn gut composition and evaluation of the anti-streptococcus activity of Bifidobacterium strains. Appl Microbiol Biotechnol 98 (2014), 6051–6060.
Tanaka, K., Iwashita, M., Matsushima, M., Wachi, Y., Izawa, T., Sakai, K., et al. Intrapartum group B Streptococcus screening using real-time polymerase chain reaction in Japanese population. J Matern Fetal Neonatal Med 29 (2016), 130–134.
Gritz, E.C., Bhandari, V., The human neonatal gut microbiome: a brief review. Front Pediatr, 3, 2015, 17.
Azad, M.B., Konya, T., Persaud, R.R., Guttman, D.S., Chari, R.S., Field, C.J., et al. Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study. BJOG 123 (2016), 983–993.
Heath, P.T., Status of vaccine research and development of vaccines for GBS. Vaccine 34 (2016), 2876–2879.
Johri, A.K., Paoletti, L.C., Glaser, P., Dua, M., Sharma, P.K., Grandi, G., et al. Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol 4 (2006), 932–942.
Maione, D., Margarit, I., Rinaudo, C.D., Masignani, V., Mora, M., Scarselli, M., et al. Identification of a universal Group B Streptococcus vaccine by multiple genome screen. Science 309 (2005), 148–150.
Cutland, C.L., Madhi, S.A., Zell, E.R., Kuwanda, L., Laque, M., Groome, M., et al. Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet 374 (2009), 1909–1916.
McClure, E.M., Goldenberg, R.L., Infection and stillbirth. Semin Fetal Neonatal Med 14 (2009), 182–189.
Lawn, J.E., Blencowe, H., Waiswa, P., Amouzou, A., Mathers, C., Hogan, D., et al. Stillbirths: rates, risk factors, and acceleration towards 2030. Lancet 387 (2016), 587–603.
de Bernis, L., Kinney, M.V., Stones, W., Ten Hoope-Bender, P., Vivio, D., Leisher, S.H., et al. Stillbirths: ending preventable deaths by 2030. Lancet 387 (2016), 703–716.
Stanton, C., Lawn, J.E., Rahman, H., Wilczynska-Ketende, K., Hill, K., Stillbirth rates: delivering estimates in 190 countries. Lancet 367 (2006), 1487–1494.
Petersson, K., Bremme, K., Bottinga, R., Hofsjo, A., Hulthen-Varli, I., Kublickas, M., et al. Diagnostic evaluation of intrauterine fetal deaths in Stockholm 1998–99. Acta Obstet Gynecol Scand 81 (2002), 284–292.
Rawlinson, W.D., Hall, B., Jones, C.A., Jeffery, H.E., Arbuckle, S.M., Graf, N., et al. Viruses and other infections in stillbirth: what is the evidence and what should we be doing?. Pathology 40 (2008), 149–160.
Lawn, J.E., Blencowe, H., Pattinson, R., Cousens, S., Kumar, R., Ibiebele, I., et al. Stillbirths: where? When? Why? How to make the data count?. Lancet 377 (2011), 1448–1463.
Tolockiene, E., Morsing, E., Holst, E., Herbst, A., Ljungh, A., Svenningsen, N., et al. Intrauterine infection may be a major cause of stillbirth in Sweden. Acta Obstet Gynecol Scand 80 (2001), 511–518.
Nan, C., Dangor, Z., Cutland, C.L., Edwards, M.S., Madhi, S.A., Cunnington, M.C., Maternal group B Streptococcus-related stillbirth: a systematic review. BJOG 122 (2015), 1437–1445.
Folgosa, E., Gonzalez, C., Osman, N.B., Hagerstrand, I., Bergstrom, S., Ljungh, A., A case control study of chorioamniotic infection and histological chorioamnionitis in stillbirth. APMIS 105 (1997), 329–336.
Moyo, S.R., Hagerstrand, I., Nystrom, L., Tswana, S.A., Blomberg, J., Bergstrom, S., et al. Stillbirths and intrauterine infection, histologic chorioamnionitis and microbiological findings. Int J Gynaecol Obstet 54 (1996), 115–123.